Gerald  M Reaven
Gerald M Reaven
Afiliación desconocida
No hay ninguna dirección de correo electrónico verificada.
Citado por
Citado por
Role of insulin resistance in human disease
GM Reaven
Diabetes 37 (12), 1595-1607, 1988
Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system
GM Reaven, H Lithell, L Landsberg
New England Journal of Medicine 334 (6), 374-382, 1996
Pathophysiology of insulin resistance in human disease
GM Reaven
Physiological reviews 75 (3), 473-486, 1995
Role of insulin resistance in human disease (syndrome X): an expanded definition
GM Reaven
Annual review of medicine 44 (1), 121-131, 1993
Use of metabolic markers to identify overweight individuals who are insulin resistant
T McLaughlin, F Abbasi, K Cheal, J Chu, C Lamendola, G Reaven
Annals of internal medicine 139 (10), 802-809, 2003
Fructose-induced insulin resistance and hypertension in rats.
IS Hwang, H Ho, BB Hoffman, GM Reaven
Hypertension 10 (5), 512-516, 1987
Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration
F Facchini, YDI Chen, CB Hollenbeck, GM Reaven
Jama 266 (21), 3008-3011, 1991
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance
I Zavaroni, E Bonora, M Pagliara, E Dall'Aglio, L Luchetti, G Buonanno, ...
New England Journal of Medicine 320 (11), 702-706, 1989
A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat
MJ Reed, K Meszaros, LJ Entes, MD Claypool, JG Pinkett, TM Gadbois, ...
Metabolism-Clinical and Experimental 49 (11), 1390-1394, 2000
Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease
G Reaven
Circulation 106 (3), 286-288, 2002
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM
GM Reaven, C Hollenbeck, CY Jeng, MS Wu, YDI Chen
Diabetes 37 (8), 1020-1024, 1988
Insulin resistance and cigarette smoking
FS Facchini, CB Hollenbeck, J Jeppesen, YDI Chen, GM Reaven
The Lancet 339 (8802), 1128-1130, 1992
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles
GM Reaven, YDI Chen, J Jeppesen, P Maheux, RM Krauss
The Journal of clinical investigation 92 (1), 141-146, 1993
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
KY Lin, A Ito, T Asagami, PS Tsao, S Adimoolam, M Kimoto, H Tsuji, ...
Circulation 106 (8), 987-992, 2002
Relationship between obesity, insulin resistance, and coronary heart disease risk
F Abbasi, BW Brown, C Lamendola, T McLaughlin, GM Reaven
Journal of the American College of Cardiology 40 (5), 937-943, 2002
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor
MC Stühlinger, F Abbasi, JW Chu, C Lamendola, TL McLaughlin, ...
Jama 287 (11), 1420-1426, 2002
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals
G Reaven
Endocrinology and Metabolism Clinics 33 (2), 283-303, 2004
Insulin resistance as a predictor of age-related diseases
FS Facchini, N Hua, F Abbasi, GM Reaven
The Journal of Clinical Endocrinology & Metabolism 86 (8), 3574-3578, 2001
The metabolic syndrome: is this diagnosis necessary? 1, 2
GM Reaven
The American journal of clinical nutrition 83 (6), 1237-1247, 2006
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation
RK Simmons, K Alberti, EAM Gale, S Colagiuri, J Tuomilehto, Q Qiao, ...
Diabetologia 53, 600-605, 2010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20